DIMITRIOS P AGALIOTIS

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology FERNANDINA BEACH, FL NPI 1790764272

General Payments — all program years on this page

$24,396.73

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 228
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,436.94 across 10 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,845.002
Travel and Lodging $358.603
Food and Beverage $233.345

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Karyopharm Therapeutics Inc. $2,843.605
Acerta Pharma LLC $436.172
E.R. Squibb & Sons, L.L.C. $120.871
PFIZER INC. $19.311
Lilly USA, LLC $16.991

By program year

Program yearAmountRecords
2018 $1,620.7428
2019 $8,309.4644
2020 $6,517.4345
2021 $2,615.1973
2022 $615.556
2023 $1,281.4222
2024 $3,436.9410

Records — PY2024 (10)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101379786 E.R. Squibb & Sons, L.L.C. $120.87 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105467189 AstraZeneca Pharmaceuticals LP $400.00 04/27/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105524881 AstraZeneca Pharmaceuticals LP $36.17 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131335709 PFIZER INC. $19.31 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136155927 Lilly USA, LLC $16.99 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145529202 Karyopharm Therapeutics Inc. $12.00 06/11/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1145529205 Karyopharm Therapeutics Inc. $40.00 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145529210 Karyopharm Therapeutics Inc. $46.81 04/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1145529214 Karyopharm Therapeutics Inc. $2,445.00 05/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1145529218 Karyopharm Therapeutics Inc. $299.79 04/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.